This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of various therapeutic agents, especially those targeting neurological and psychiatric disorders. Its structure is often incorporated into molecules designed to interact with specific receptors in the central nervous system, potentially aiding in the treatment of conditions such as anxiety, depression, or cognitive impairments. Additionally, it may be explored in the development of drugs with improved bioavailability and targeted delivery mechanisms. Researchers also investigate its potential in creating enantiomerically pure compounds, which are critical for ensuring the efficacy and safety of chiral drugs.